Your browser doesn't support javascript.
loading
The use of comprehensive geriatric assessment in older patients before allologeneic hematopoietic stem cell transplantation: A cross-sectional study.
Rodrigues, Morgani; de Souza, Polianna Mara Rodrigues; de Oliveira Muniz Koch, Ludmila; Hamerschlak, Nelson.
Afiliación
  • Rodrigues M; Department of Hematology, Hospital Israelita Albert Einstein, São Paulo (SP), Brazil. Electronic address: morgani.rodrigues@einstein.br.
  • de Souza PMR; Geriatrician of department of Oncology and Hematology, Hospital Israelita Albert Einstein, São Paulo, Brazil. Electronic address: polianna.souza@einstein.br.
  • de Oliveira Muniz Koch L; Department of Oncology, Hospital Israelita Albert Einstein, São Paulo (SP), Brazil. Electronic address: ludmila.koch@einstein.br.
  • Hamerschlak N; Department of Hematology, Hospital Israelita Albert Einstein, São Paulo (SP), Brazil. Electronic address: hamer@einstein.br.
J Geriatr Oncol ; 11(1): 100-106, 2020 01.
Article en En | MEDLINE | ID: mdl-31230926
ABSTRACT

OBJECTIVES:

To evaluate the results of the comprehensive geriatric assessment (CGA) before allogeneic hematopoietic stem cell (HSCT) transplantation in patients aged 60 years and over.

METHODS:

We evaluated all consecutive patients undergoing CGA before HSCT between September 2011 and July 2018 in a private hospital in Brazil. We also evaluated the Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-SCI) and the Disease Risk Index (DRI).

RESULTS:

During the study period, 61 patients were referred for transplant evaluation. After exclusions, we analyzed 40 patients, with a mean age of 67.6 years (60-76). The CGA detected vulnerability and frailty in 43% and 18.9% respectively according to the Fried Frailty Phenotype score; limitations across the domain of function and disability with handgrip test alterations in 65.8%. However, 36 (90%) were independent for instrumental activities of daily living (IADL). Cognitive and depression domain have shown abnormal with the clock test in 44.4%, and loss of memory complains in 37.5%. But the mini-mental test was normal in 89%. Geriatric Depression Scale (GDS) was normal in 82.5%. 30% were considered at risk for malnutrition. Half of the patients (50%) had a high Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) score. 32.5% needed ICU admission. The overall survival and non-relapse mortality at 2 years were 41.8% and 38.7% respectively.

CONCLUSION:

The CGA was feasible in detecting the patients' vulnerabilities in our population. More studies, multicentric and with a larger number of patients, are needed to evaluate the role of CGA in this context of allo-HCT in our population.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Evaluación Geriátrica / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Clinical_trials / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Aged / Humans País/Región como asunto: America do sul / Brasil Idioma: En Revista: J Geriatr Oncol Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Evaluación Geriátrica / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Clinical_trials / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Aged / Humans País/Región como asunto: America do sul / Brasil Idioma: En Revista: J Geriatr Oncol Año: 2020 Tipo del documento: Article